Multi-hospital analysis of antimicrobial usage and resistance trends

被引:41
作者
Lesch, CA [1 ]
Itokazu, GS
Danziger, LH
Weinstein, RA
机构
[1] Univ Illinois, Dept Pharm Practice, Chicago, IL 60637 USA
[2] Cook Cty Hosp, Chicago, IL 60612 USA
关键词
D O I
10.1016/S0732-8893(01)00296-6
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
We report a pilot study comparing antimicrobial usage and antimicrobial resistance trends for prominent nosocomial pathogens between 1994-1996 A convenience sample of ten hospitals participated in this retrospective review. We found a large variation in antimicrobial use and resistance trends and that many hospitals did not have data readily available to evaluate drug usage and resistance rates. A significant strong positive correlation was observed between the usage of ceftazidime and the prevalence of ceftazidime resistant Pseudomonas aeruginosa (r = 0.8, p = 0.005) and of ceftazidime resistant Enterobacter species (r = 0.8, p = 0.02). The presence of antibiotic control policies correlated with lower rates of some resistant strains and less antibiotic use. Our findings can be a useful starting point for hospitals that want to systematically measure antimicrobial use and resistance. Hospital laboratories, pharmacies, and infection control departments must work together to develop databases that will facilitate such measurements. (C) 2001 Elsevier Science Inc. All rights reserved.
引用
收藏
页码:149 / 154
页数:6
相关论文
共 30 条
[1]  
AMSDEN GW, 1995, PRINCIPLES PRACTICE, P506
[2]   Antimicrobial resistance in isolates from inpatients and outpatients in the united states: Increasing importance of the intensive care unit [J].
Archibald, L ;
Phillips, L ;
Monnet, D ;
McGowan, JE ;
Tenover, F ;
Gaynes, R .
CLINICAL INFECTIOUS DISEASES, 1997, 24 (02) :211-215
[3]   Third-generation cephalosporins and vancomycin as risk factors for postoperative vancomycin-resistant Enterococcus infection [J].
Dahms, RA ;
Johnson, EM ;
Statz, CL ;
Lee, JT ;
Dunn, DL ;
Beilman, GJ .
ARCHIVES OF SURGERY, 1998, 133 (12) :1343-1346
[4]   A 25-year study of nosocomial bacteremia in an adult intensive care unit [J].
Edgeworth, JD ;
Treacher, DF ;
Eykyn, SJ .
CRITICAL CARE MEDICINE, 1999, 27 (08) :1421-1428
[5]   Effect of vancomycin on intestinal flora of patients who previously received antimicrobial therapy [J].
Edlund, C ;
Barkholt, L ;
OlssonLiljequist, B ;
Nord, CE .
CLINICAL INFECTIOUS DISEASES, 1997, 25 (03) :729-732
[6]   VANCOMYCIN-RESISTANT ENTEROCOCCUS-FAECIUM BACTEREMIA - RISK-FACTORS FOR INFECTION [J].
EDMOND, MB ;
OBER, JF ;
WEINBAUM, DL ;
PFALLER, MA ;
HWANG, T ;
SANFORD, MD ;
WENZEL, RP .
CLINICAL INFECTIOUS DISEASES, 1995, 20 (05) :1126-1133
[7]   Determinants of vancomycin use in adult intensive care units in 41 United States hospitals [J].
Fridkin, SK ;
Edwards, JR ;
Pichette, SC ;
Pryor, ER ;
McGowan, JE ;
Tenover, FC ;
Culver, DH ;
Gaynes, RP .
CLINICAL INFECTIOUS DISEASES, 1999, 28 (05) :1119-1125
[8]   Is there a relationship between vancomycin-resistant enterococcal infection and Clostridium difficile infection? [J].
Gerding, DN .
CLINICAL INFECTIOUS DISEASES, 1997, 25 :S206-S210
[9]  
Gindler J. S., 1995, Morbidity and Mortality Weekly Report, V44, P1
[10]   VANCOMYCIN-RESISTANT ENTEROCOCCI COLONIZING THE INTESTINAL TRACTS OF HOSPITALIZED-PATIENTS [J].
GORDTS, B ;
VANLANDUYT, H ;
IEVEN, M ;
VANDAMME, P ;
GOOSSENS, H .
JOURNAL OF CLINICAL MICROBIOLOGY, 1995, 33 (11) :2842-2846